RxNorm Semantic Concepts Index - 125
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "125".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 125000 | ODC - Orotidine-5'-monophosphate decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125000 | ODC - Orotidine-5'-monophosphate decarboxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125000 | ODC - Orotidine-5'-monophosphate decarboxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125001 | SAH - S-Adenosyl homocysteine hydrolase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125001 | SAH - S-Adenosyl homocysteine hydrolase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125001 | SAH - S-Adenosyl homocysteine hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125002 | UMP - Uridyl monophosphate hydrolase 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125002 | UMP - Uridyl monophosphate hydrolase 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125002 | UMP - Uridyl monophosphate hydrolase 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125003 | UMP - Uridyl monophosphate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125003 | UMP - Uridyl monophosphate synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125003 | UMP - Uridyl monophosphate synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125005 | Corticosterone methyl oxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125005 | Corticosterone methyl oxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125006 | Alpha-1-antitrypsin isoform | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125006 | Alpha-1-antitrypsin isoform | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125006 | Alpha-1-antitrypsin isoform | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250064 | fluorometholone acetate 1 MG/ML [Eflone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250065 | fluorometholone acetate 1 MG/ML Ophthalmic Suspension [Eflone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250065 | fluorometholone acetate 1 MG/ML Ophthalmic Suspension [Eflone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250065 | fluorometholone acetate 1 MG/ML Ophthalmic Suspension [Eflone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125007 | Alpha-1-antitrypsin isoform M | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125007 | Alpha-1-antitrypsin isoform M | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125008 | Alpha-1-antitrypsin isoform null | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125008 | Alpha-1-antitrypsin isoform null | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250089 | nonoxynol-9 0.03 MG/MG [Gynol II] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250090 | GYNOL II Extra Strength 3 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250090 | GYNOL II Extra Strength 3 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250090 | GYNOL II Extra Strength 3 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250090 | GYNOL II Extra Strength 3 % Vaginal Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250091 | midazolam (as midazolam hydrochloride) 0.5 MG per 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250091 | midazolam (as midazolam hydrochloride) 0.5 MG per 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125015 | Lipoprotein (a)-isoform | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125015 | Lipoprotein (a)-isoform | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250169 | 0.1 ML Lidocaine Hydrochloride 1 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250169 | 0.1 ML Lidocaine Hydrochloride 1 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250169 | 0.1 ML Lidocaine Hydrochloride 1 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250170 | 0.2 ML lidocaine hydrochloride 1 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250170 | 0.2 ML lidocaine hydrochloride 1 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250170 | 0.2 ML lidocaine hydrochloride 1 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250174 | ethanol 85 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250174 | ethanol 85 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250174 | ethanol 85 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125018 | Minimally modified low density lipoprotein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125018 | Minimally modified low density lipoprotein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250182 | menthol 2.7 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250183 | Halls 2.7 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250183 | Halls 2.7 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250183 | Halls 2.7 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250184 | menthol 4.6 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250185 | Halls 4.6 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250185 | Halls 4.6 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250185 | Halls 4.6 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250186 | menthol 5.4 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250187 | Halls 5.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250187 | Halls 5.4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250187 | Halls 5.4 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250188 | menthol 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250189 | menthol 7.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250189 | menthol 7.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 125019 | Chylomicron remnants | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125019 | Chylomicron remnants | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250190 | menthol 7.5 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250191 | Halls 7.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250191 | Halls 7.5 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250191 | Halls 7.5 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250192 | menthol 8.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1250193 | Menthol 8.2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250193 | Menthol 8.2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250194 | menthol 8.2 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250195 | Halls 8.2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250195 | Halls 8.2 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250195 | Halls 8.2 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250203 | robenacoxib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1250204 | robenacoxib 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1250205 | robenacoxib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1250206 | robenacoxib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1250207 | robenacoxib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1250208 | robenacoxib 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250208 | robenacoxib 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250209 | Onsior | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 125021 | 3.8S alpha-2 glycoprotein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125021 | 3.8S alpha-2 glycoprotein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250210 | robenacoxib 6 MG [Onsior] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250211 | robenacoxib Oral Tablet [Onsior] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250212 | Onsior Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250213 | Onsior Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250214 | Onsior 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250214 | Onsior 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250214 | Onsior 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125022 | Antichymotrypsin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125022 | Antichymotrypsin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125023 | Apolipoprotein A-I structural variant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125023 | Apolipoprotein A-I structural variant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250230 | aluminum sulfate 8.42 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250231 | calcium acetate 5.95 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250232 | aluminum sulfate / calcium acetate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1250233 | aluminum sulfate / calcium acetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1250234 | aluminum sulfate 1347 MG / calcium acetate 952 MG per 160 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250234 | aluminum sulfate 1347 MG / calcium acetate 952 MG per 160 ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250234 | aluminum sulfate 1347 MG / calcium acetate 952 MG per 160 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250234 | aluminum sulfate 1347 MG / calcium acetate 952 MG per 160 ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 125025 | Apolipoprotein (a) isoform | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125025 | Apolipoprotein (a) isoform | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125026 | Beta 1 globulin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125026 | Beta 1 globulin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125027 | Beta 2 globulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125027 | Beta 2 globulin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125027 | Beta 2 globulin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1250278 | aluminum hydroxide 160 MG / magnesium carbonate 105 MG [Acid Gone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250279 | aluminum hydroxide / magnesium carbonate Chewable Tablet [Acid Gone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125028 | Binding protein 3 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125028 | Binding protein 3 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250281 | Acid Gone Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1250282 | Acid Gone Extra Strength 160 MG / 105 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250282 | Acid Gone Extra Strength 160 MG / 105 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250282 | Acid Gone Extra Strength 160 MG / 105 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125029 | Lymphocyte light chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125029 | Lymphocyte light chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125030 | Lymphocyte heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125030 | Lymphocyte heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125030 | Lymphocyte heavy chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125031 | Cytoplasmic gamma chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125031 | Cytoplasmic gamma chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125032 | Cytoplasmic alpha chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125032 | Cytoplasmic alpha chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125033 | Cytoplasmic delta chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125033 | Cytoplasmic delta chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125034 | Cytoplasmic kappa chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125034 | Cytoplasmic kappa chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125035 | Cytoplasmic mu chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125035 | Cytoplasmic mu chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125036 | Cytoplasmic epsilon chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125036 | Cytoplasmic epsilon chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125037 | Cytoplasmic lambda chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125037 | Cytoplasmic lambda chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125039 | Immunoglobulin IgM, 7s type | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125039 | Immunoglobulin IgM, 7s type | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125039 | Immunoglobulin IgM, 7s type | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125040 | Specific antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125040 | Specific antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125041 | Anti-immunoglobulin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125041 | Anti-immunoglobulin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125042 | Brucella antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125042 | Brucella antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125042 | Brucella antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125043 | Chlamydia antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125043 | Chlamydia antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125043 | Chlamydia antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250433 | hydromorphone hydrochloride 0.5 MG per 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250433 | hydromorphone hydrochloride 0.5 MG per 1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250433 | hydromorphone hydrochloride 0.5 MG per 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250433 | hydromorphone hydrochloride 0.5 MG per 1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 125044 | Chlamydia trachomatis serotype A antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125044 | Chlamydia trachomatis serotype A antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250449 | camphor 4.7 % / eucalyptus oil 1.2 % / menthol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250449 | camphor 4.7 % / eucalyptus oil 1.2 % / menthol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250449 | camphor 4.7 % / eucalyptus oil 1.2 % / menthol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125045 | Chlamydia trachomatis serotype B antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125045 | Chlamydia trachomatis serotype B antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125046 | Chlamydia trachomatis serotype Ba antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125046 | Chlamydia trachomatis serotype Ba antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125047 | Chlamydia trachomatis serotype C antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125047 | Chlamydia trachomatis serotype C antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250472 | diphenhydrAMINE / phenol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1250472 | diphenhydrAMINE / phenol Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250473 | diphenhydramine hydrochloride 1 % / phenol 1.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250473 | diphenhydramine hydrochloride 1 % / phenol 1.4 % Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250473 | diphenhydramine hydrochloride 1 % / phenol 1.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250473 | diphenhydramine hydrochloride 1 % / phenol 1.4 % Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250474 | Dermagesic Itch Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250475 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML [Dermagesic Itch Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250475 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML [Dermagesic Itch Relief] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250476 | diphenhydrAMINE / phenol Topical Solution [Dermagesic Itch Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250476 | diphenhydrAMINE / phenol Topical Solution [Dermagesic Itch Relief] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250477 | Dermagesic Itch Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250478 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML Topical Solution [Dermagesic Itch Relief] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250478 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML Topical Solution [Dermagesic Itch Relief] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1250478 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML Topical Solution [Dermagesic Itch Relief] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250478 | diphenhydramine hydrochloride 10 MG/ML / phenol 14 MG/ML Topical Solution [Dermagesic Itch Relief] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 125048 | Chlamydia trachomatis serotype D antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125048 | Chlamydia trachomatis serotype D antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250483 | chromium picolinate 0.805 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250484 | inulin 1.5 GM / chromium 100 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250484 | inulin 1.5 GM / chromium 100 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250484 | inulin 1.5 GM / chromium 100 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250485 | hydrocortisone acetate 10 MG/ML [Carmol HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250486 | CARMOL HC 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250486 | CARMOL HC 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250486 | CARMOL HC 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250486 | CARMOL HC 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250487 | hydrocortisone acetate 10 MG/ML [Corticaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250488 | hydrocortisone acetate 10 MG/ML Topical Cream [Corticaine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250488 | hydrocortisone acetate 10 MG/ML Topical Cream [Corticaine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250488 | hydrocortisone acetate 10 MG/ML Topical Cream [Corticaine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125049 | Chlamydia trachomatis serotype E antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125049 | Chlamydia trachomatis serotype E antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250490 | hydrocortisone acetate 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250490 | hydrocortisone acetate 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250490 | hydrocortisone acetate 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250491 | hydrocortisone acetate 5 MG/ML [Corticaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250492 | hydrocortisone acetate 5 MG/ML Topical Cream [Corticaine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250492 | hydrocortisone acetate 5 MG/ML Topical Cream [Corticaine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250492 | hydrocortisone acetate 5 MG/ML Topical Cream [Corticaine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250493 | hydrocortisone acetate 10 MG/ML [Hycort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250494 | hydrocortisone acetate 10 MG/ML Topical Cream [Hycort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250494 | hydrocortisone acetate 10 MG/ML Topical Cream [Hycort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250494 | hydrocortisone acetate 10 MG/ML Topical Cream [Hycort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250495 | acetaminophen 325 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 250 MG [Cafgesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250496 | Cafgesic 325 MG / 50 MG / 20 MG / 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250496 | Cafgesic 325 MG / 50 MG / 20 MG / 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250496 | Cafgesic 325 MG / 50 MG / 20 MG / 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250496 | Cafgesic 325 MG / 50 MG / 20 MG / 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250499 | APAP 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250499 | APAP 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125050 | Chlamydia trachomatis serotype F antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125050 | Chlamydia trachomatis serotype F antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250504 | acetaminophen 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG [Cafgesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250505 | acetaminophen / caffeine / phenyltoloxamine / salicylamide Oral Tablet [Cafgesic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250508 | acetaminophen 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG Oral Tablet [Cafgesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250508 | acetaminophen 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG Oral Tablet [Cafgesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250508 | acetaminophen 500 MG / caffeine 50 MG / phenyltoloxamine citrate 20 MG / salicylamide 500 MG Oral Tablet [Cafgesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125051 | Chlamydia trachomatis serotype G antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125051 | Chlamydia trachomatis serotype G antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125052 | Chlamydia trachomatis serotype H antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125052 | Chlamydia trachomatis serotype H antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250528 | APAP 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 8 OZ. Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250528 | APAP 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 8 OZ. Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250528 | APAP 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 8 OZ. Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250528 | APAP 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG per 8 OZ. Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125053 | Chlamydia trachomatis serotype I antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125053 | Chlamydia trachomatis serotype I antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125054 | Chlamydia trachomatis serotype J antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125054 | Chlamydia trachomatis serotype J antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250541 | acetaminophen 600 MG / phenyltoloxamine citrate 66 MG [Lagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250542 | Lagesic 600 MG / 66 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250542 | Lagesic 600 MG / 66 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250542 | Lagesic 600 MG / 66 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250542 | Lagesic 600 MG / 66 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250543 | acetaminophen 600 MG / phenyltoloxamine citrate 66 MG [QFlex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250544 | acetaminophen 600 MG / phenyltoloxamine citrate 66 MG Extended Release Oral Tablet [QFlex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250544 | acetaminophen 600 MG / phenyltoloxamine citrate 66 MG Extended Release Oral Tablet [QFlex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250544 | acetaminophen 600 MG / phenyltoloxamine citrate 66 MG Extended Release Oral Tablet [QFlex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250545 | Cruex Powder | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250546 | calcium undecylenate 0.1 MG/MG [Cruex Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250547 | undecylenate Topical Powder [Cruex Powder] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250548 | Cruex Powder Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250549 | calcium undecylenate 0.1 MG/MG Topical Powder [Cruex Powder] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250549 | calcium undecylenate 0.1 MG/MG Topical Powder [Cruex Powder] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250549 | calcium undecylenate 0.1 MG/MG Topical Powder [Cruex Powder] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125055 | Chlamydia trachomatis serotype K antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125055 | Chlamydia trachomatis serotype K antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250554 | undecylenic acid 1 % Powder Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250554 | undecylenic acid 1 % Powder Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250554 | undecylenic acid 1 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250555 | Breezee Mist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250556 | undecylenic acid 0.01 MG/MG [Breezee Mist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250557 | undecylenate Powder Spray [Breezee Mist] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250558 | Breezee Mist Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250559 | Breezee Mist 1 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250559 | Breezee Mist 1 % Powder Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250559 | Breezee Mist 1 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250559 | Breezee Mist 1 % Powder Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125056 | Chlamydia trachomatis serotype L1 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125056 | Chlamydia trachomatis serotype L1 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250560 | undecylenic acid 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250560 | undecylenic acid 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250560 | undecylenic acid 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250563 | chloroxylenol 3 % / undecylenic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250563 | chloroxylenol 3 % / undecylenic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250563 | chloroxylenol 3 % / undecylenic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250564 | oxybutynin 0.03 MG/MG [Gelnique] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250565 | Gelnique 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250565 | Gelnique 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250565 | Gelnique 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250565 | Gelnique 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250565 | Gelnique 3 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125057 | Chlamydia trachomatis serotype L2 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125057 | Chlamydia trachomatis serotype L2 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125058 | Chlamydia trachomatis serotype L3 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125058 | Chlamydia trachomatis serotype L3 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125060 | Chlamydia psittaci biogroup 1 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125060 | Chlamydia psittaci biogroup 1 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125060 | Chlamydia psittaci biogroup 1 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125061 | Chlamydia psittaci biogroup 2 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125061 | Chlamydia psittaci biogroup 2 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125061 | Chlamydia psittaci biogroup 2 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125062 | Chlamydia psittaci biogroup 4 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125062 | Chlamydia psittaci biogroup 4 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125062 | Chlamydia psittaci biogroup 4 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125063 | Chlamydia psittaci biogroup 5 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125063 | Chlamydia psittaci biogroup 5 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125063 | Chlamydia psittaci biogroup 5 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250630 | allantoin / benzalkonium Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1250631 | allantoin 1 % / benzalkonium chloride 0.13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250631 | allantoin 1 % / benzalkonium chloride 0.13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250631 | allantoin 1 % / benzalkonium chloride 0.13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250637 | allantoin 1 % / benzethonium chloride 0.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250637 | allantoin 1 % / benzethonium chloride 0.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250637 | allantoin 1 % / benzethonium chloride 0.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125064 | Chlamydia psittaci biogroup 7 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125064 | Chlamydia psittaci biogroup 7 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125064 | Chlamydia psittaci biogroup 7 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250644 | Femmesil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250645 | miconazole nitrate 0.02 MG/MG [Femmesil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250647 | Femmesil Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 125065 | Chlamydia psittaci biogroup 8 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125065 | Chlamydia psittaci biogroup 8 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125065 | Chlamydia psittaci biogroup 8 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250653 | Nexiclear Acne Treatment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250654 | salicylic acid 20 MG/ML [Nexiclear Acne Treatment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250655 | salicylic acid Medicated Pad [Nexiclear Acne Treatment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250656 | Nexiclear Acne Treatment Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250657 | Nexiclear Acne Treatment 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250657 | Nexiclear Acne Treatment 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250657 | Nexiclear Acne Treatment 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250657 | Nexiclear Acne Treatment 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125066 | Chlamydia psittaci biogroup 3 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125066 | Chlamydia psittaci biogroup 3 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125066 | Chlamydia psittaci biogroup 3 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250663 | acyclovir 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1250664 | acyclovir / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1250665 | acyclovir / lidocaine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1250666 | acyclovir / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1250667 | acyclovir 4 % / lidocaine HCl 4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250667 | acyclovir 4 % / lidocaine HCl 4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250667 | acyclovir 4 % / lidocaine HCl 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250667 | acyclovir 4 % / lidocaine HCl 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250668 | Lidovir | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250669 | acyclovir 0.04 MG/MG / lidocaine hydrochloride 0.04 MG/MG [Lidovir] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 125067 | Chlamydia psittaci biogroup 6 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125067 | Chlamydia psittaci biogroup 6 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125067 | Chlamydia psittaci biogroup 6 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250670 | acyclovir / lidocaine Topical Ointment [Lidovir] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250671 | Lidovir Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250672 | LidoVir 4 % / 4 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250672 | LidoVir 4 % / 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250672 | LidoVir 4 % / 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250672 | LidoVir 4 % / 4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 125068 | Diphtheria toxoid antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125068 | Diphtheria toxoid antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125068 | Diphtheria toxoid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250684 | loperamide Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1250685 | loperamide HCl 1 MG in 7.5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1250686 | Fiber Choice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1250687 | inulin 1500 MG [Fiber Choice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250688 | inulin Chewable Tablet [Fiber Choice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250689 | Fiber Choice Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 125069 | Q fever antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125069 | Q fever antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125069 | Q fever antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250690 | Fiber Choice Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1250691 | Fiber Choice 1.5 GM Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250691 | Fiber Choice 1.5 GM Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250691 | Fiber Choice 1.5 GM Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250692 | loperamide Oral Suspension [Imodium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250693 | Imodium A-D 1 MG in 7.5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250693 | Imodium A-D 1 MG in 7.5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250693 | Imodium A-D 1 MG in 7.5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250693 | Imodium A-D 1 MG in 7.5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125070 | Q I antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125070 | Q I antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125070 | Q I antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125071 | Q II antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125071 | Q II antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125071 | Q II antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250713 | Fiber Choice Weight Management | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1250714 | chromium picolinate 0.805 MG / inulin 1500 MG [Fiber Choice Weight Management] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250716 | Fiber Choice Weight Management 1.5 GM / 100 MCG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250716 | Fiber Choice Weight Management 1.5 GM / 100 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250716 | Fiber Choice Weight Management 1.5 GM / 100 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 125072 | Legionella pneumophila serogroup 1 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125072 | Legionella pneumophila serogroup 1 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250720 | etravirine 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250721 | etravirine 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250721 | etravirine 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1250721 | etravirine 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250721 | etravirine 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1250722 | etravirine 25 MG [Intelence] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250723 | INTELENCE 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250723 | INTELENCE 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250723 | INTELENCE 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250724 | clotrimazole 10 MG/ML [Pedesil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250725 | clotrimazole Topical Cream [Pedesil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250726 | Pedesil 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250726 | Pedesil 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250726 | Pedesil 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250726 | Pedesil 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250727 | miconazole nitrate 20 MG/ML [Femmesil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250728 | miconazole Topical Cream [Femmesil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250729 | Femmesil 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250729 | Femmesil 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250729 | Femmesil 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250729 | Femmesil 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125073 | Listeria antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125073 | Listeria antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125073 | Listeria antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250730 | Vite20 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250731 | undecylenic acid 100 MG/ML [Vite20] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250732 | undecylenate Topical Cream [Vite20] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250733 | Vite20 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250734 | Vite20 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250734 | Vite20 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250734 | Vite20 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250734 | Vite20 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125074 | Mycobacterium tuberculosis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125074 | Mycobacterium tuberculosis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250743 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250743 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250743 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 125075 | Neisseria meningitidis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125075 | Neisseria meningitidis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250751 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 0.625 MG / phenylephrine hydrochloride 10 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250751 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 0.625 MG / phenylephrine hydrochloride 10 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250754 | zinc undecylenate 0.12 MG/MG [Blis-To-Sol Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250755 | Blis-To-Sol 12 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250755 | Blis-To-Sol 12 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250755 | Blis-To-Sol 12 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250755 | Blis-To-Sol 12 % Topical Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125076 | Meningococcal antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125076 | Meningococcal antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125077 | Neisseria meningitidis polysaccharide group A antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125077 | Neisseria meningitidis polysaccharide group A antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125077 | Neisseria meningitidis polysaccharide group A antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125078 | Neisseria meningitidis polysaccharide group C antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125078 | Neisseria meningitidis polysaccharide group C antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125078 | Neisseria meningitidis polysaccharide group C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125080 | Pseudomonas aeruginosa antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125080 | Pseudomonas aeruginosa antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125081 | Salmonella Typhi antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125081 | Salmonella Typhi antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125082 | Salmonella Typhi Vi antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125082 | Salmonella Typhi Vi antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125083 | Salmonella serovar Paratyphi A antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125083 | Salmonella serovar Paratyphi A antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125083 | Salmonella serovar Paratyphi A antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125084 | Salmonella Paratyphi A O antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125084 | Salmonella Paratyphi A O antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125084 | Salmonella Paratyphi A O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125084 | Salmonella Paratyphi A O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125085 | Salmonella Paratyphi A H antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125085 | Salmonella Paratyphi A H antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125085 | Salmonella Paratyphi A H antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125086 | Salmonella Paratyphi B antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125086 | Salmonella Paratyphi B antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125086 | Salmonella Paratyphi B antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125087 | Salmonella Paratyphi B H antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125087 | Salmonella Paratyphi B H antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125087 | Salmonella Paratyphi B H antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125087 | Salmonella Paratyphi B H antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125088 | Salmonella Paratyphi B O antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125088 | Salmonella Paratyphi B O antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125088 | Salmonella Paratyphi B O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125088 | Salmonella Paratyphi B O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125089 | Salmonella serovar Paratyphi C antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125089 | Salmonella serovar Paratyphi C antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125089 | Salmonella serovar Paratyphi C antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250895 | calcium undecylenate 0.15 MG/MG [Protectol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250896 | calcium undecylenate 0.15 MG/MG Topical Powder [Protectol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250896 | calcium undecylenate 0.15 MG/MG Topical Powder [Protectol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250896 | calcium undecylenate 0.15 MG/MG Topical Powder [Protectol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250898 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125090 | Salmonella Paratyphi C O antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125090 | Salmonella Paratyphi C O antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125090 | Salmonella Paratyphi C O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125090 | Salmonella Paratyphi C O antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250900 | undecylenic acid 10 MG/ML [Diabetiderm Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250901 | undecylenic acid 10 MG/ML Topical Cream [Diabetiderm Antifungal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250901 | undecylenic acid 10 MG/ML Topical Cream [Diabetiderm Antifungal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250902 | undecylenic acid 100 MG/ML [Diabetiderm Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250903 | Diabetiderm Antifungal 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250903 | Diabetiderm Antifungal 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250903 | Diabetiderm Antifungal 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250903 | Diabetiderm Antifungal 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250904 | chlorpheniramine maleate 4 MG / phenylephrine HCl 20 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250904 | chlorpheniramine maleate 4 MG / phenylephrine HCl 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250906 | diphenhydramine citrate 38.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250906 | diphenhydramine citrate 38.3 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250907 | aspirin 500 MG / diphenhydrAMINE citrate 38.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250907 | aspirin 500 MG / diphenhydrAMINE citrate 38.3 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250907 | aspirin 500 MG / diphenhydrAMINE citrate 38.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250907 | aspirin 500 MG / diphenhydrAMINE citrate 38.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250907 | aspirin 500 MG / diphenhydrAMINE citrate 38.3 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250908 | aspirin 500 MG / diphenhydramine citrate 38.3 MG [Bayer Aspirin PM Reformulated Nov 2011] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250908 | aspirin 500 MG / diphenhydramine citrate 38.3 MG [Bayer Aspirin PM Reformulated Nov 2011] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250909 | BAYER Aspirin PM 500 MG / 38.3 MG Oral Tablet, Reformulated Nov 2011 | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 125091 | Salmonella Paratyphi C H antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125091 | Salmonella Paratyphi C H antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125091 | Salmonella Paratyphi C H antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125091 | Salmonella Paratyphi C H antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250910 | undecylenic acid 250 MG/ML [Elon Dual Defense] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250911 | Elon Dual Defense 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250911 | Elon Dual Defense 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250911 | Elon Dual Defense 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250911 | Elon Dual Defense 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250912 | undeclyenic acid 2 % / zinc undecylenate 20 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250912 | undeclyenic acid 2 % / zinc undecylenate 20 % Powder Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250913 | Cruex Powder Spray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1250914 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG [Cruex Powder Spray] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250915 | undecylenate Powder Spray [Cruex Powder Spray] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250916 | Cruex Powder Spray Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1250917 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG Powder Spray [Cruex Powder Spray] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250917 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG Powder Spray [Cruex Powder Spray] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250918 | undecylenic acid 190 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1250919 | undecylenic acid 19 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250919 | undecylenic acid 19 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125092 | Pneumococcal polysaccharide antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125092 | Pneumococcal polysaccharide antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125092 | Pneumococcal polysaccharide antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250920 | undecylenic acid 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250921 | undecylenic acid 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250921 | undecylenic acid 20 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250921 | undecylenic acid 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250922 | undecylenic acid 200 MG/ML [Cruex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250923 | undecylenic acid 200 MG/ML Topical Cream [Cruex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250923 | undecylenic acid 200 MG/ML Topical Cream [Cruex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250923 | undecylenic acid 200 MG/ML Topical Cream [Cruex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250924 | zinc undecylenate 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250924 | zinc undecylenate 20 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250924 | zinc undecylenate 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250925 | undecylenic acid 10 MG/ML [Cruex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250926 | Cruex 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250926 | Cruex 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250926 | Cruex 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250926 | Cruex 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250927 | Fiber Choice Weight Management Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1250928 | Fiber Choice Weight Management Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 125093 | Streptococcus pyogenes antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125093 | Streptococcus pyogenes antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125094 | Streptococcal anti-hyaluronidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125094 | Streptococcal anti-hyaluronidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250949 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250949 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125095 | Anti-deoxyribonuclease B antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125095 | Anti-deoxyribonuclease B antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125095 | Anti-deoxyribonuclease B antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125096 | Viridans streptococcus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125096 | Viridans streptococcus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125097 | Yersinia pestis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125097 | Yersinia pestis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250973 | chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML [Notuss AC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1250974 | chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML Oral Solution [Notuss AC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1250974 | chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML Oral Solution [Notuss AC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250975 | undecylenic acid 100 MG/ML [Tineacide Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1250976 | Tineacide Antifungal 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250976 | Tineacide Antifungal 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250976 | Tineacide Antifungal 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250976 | Tineacide Antifungal 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250977 | undecylenic acid 130 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1250978 | undecylenic acid 13 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250978 | undecylenic acid 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250978 | undecylenic acid 13 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1250979 | undecylenic acid 130 MG/ML [Tineacide Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 125098 | Tetanus toxoid antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125098 | Tetanus toxoid antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125098 | Tetanus toxoid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250980 | Tineacide Antifungal 13 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250980 | Tineacide Antifungal 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250980 | Tineacide Antifungal 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1250980 | Tineacide Antifungal 13 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1250983 | 16 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule) / 8 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1250983 | 16 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule) / 8 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1250983 | 16 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule) / 8 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1250987 | propionic acid 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1250988 | propionic acid / undecylenate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1250989 | propionic acid / undecylenate Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 125099 | E. coli lipopolysaccharide antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125099 | E. coli lipopolysaccharide antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125099 | E. coli lipopolysaccharide antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1250990 | propionic acid / undecylenate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1250991 | propionic acid 2 % / undecylenic acid 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250991 | propionic acid 2 % / undecylenic acid 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250991 | propionic acid 2 % / undecylenic acid 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250992 | salicylic acid 2 % / undecylenic acid 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1250992 | salicylic acid 2 % / undecylenic acid 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250992 | salicylic acid 2 % / undecylenic acid 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250995 | salicylic acid 2 % / undecylenic acid 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1250995 | salicylic acid 2 % / undecylenic acid 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1250995 | salicylic acid 2 % / undecylenic acid 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251 | 5 azacytidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 125100 | Mycoplasma antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125100 | Mycoplasma antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125100 | Mycoplasma antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251000 | undecylenic acid 10 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251000 | undecylenic acid 10 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251000 | undecylenic acid 10 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251003 | undecylenic acid 0.25 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251004 | undecylenic acid 25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251004 | undecylenic acid 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251004 | undecylenic acid 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251005 | undecylenic acid 25 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251005 | undecylenic acid 25 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251006 | undecylenic acid 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251006 | undecylenic acid 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251006 | undecylenic acid 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251007 | undecylenic acid 10 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251007 | undecylenic acid 10 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251007 | undecylenic acid 10 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251008 | undecylenic acid 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251008 | undecylenic acid 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251008 | undecylenic acid 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 125101 | Epstein-Barr virus nuclear antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125101 | Epstein-Barr virus nuclear antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251011 | undecylenic acid 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251011 | undecylenic acid 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251011 | undecylenic acid 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251012 | undecylenic acid 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251013 | undecylenic acid 12.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251013 | undecylenic acid 12.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251013 | undecylenic acid 12.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251014 | undecylenic acid 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251014 | undecylenic acid 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251014 | undecylenic acid 2 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251019 | undecylenic acid 220 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 125102 | Epstein-Barr virus capsid antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125102 | Epstein-Barr virus capsid antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251020 | undecylenic acid 22 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251020 | undecylenic acid 22 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251020 | undecylenic acid 22 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251021 | phenylephrine hydrochloride 5 MG/ML [Sinex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251022 | Sinex Decongestant Regular 0.5 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251022 | Sinex Decongestant Regular 0.5 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251022 | Sinex Decongestant Regular 0.5 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251022 | Sinex Decongestant Regular 0.5 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251022 | Sinex Decongestant Regular 0.5 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251026 | undecylenic acid 75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251027 | undecylenic acid 7.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251027 | undecylenic acid 7.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251027 | undecylenic acid 7.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125103 | Lassa fever virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125103 | Lassa fever virus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125103 | Lassa fever virus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251031 | dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251031 | dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251031 | dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251031 | dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251031 | dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251034 | chloroxylenol 0.5 % / undecylenic acid 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251034 | chloroxylenol 0.5 % / undecylenic acid 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251034 | chloroxylenol 0.5 % / undecylenic acid 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251037 | undecylenic acid 0.22 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251038 | undecylenic acid 22 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251038 | undecylenic acid 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251039 | chlorpheniramine maleate 1 MG/ML / dextromethorphan hydrobromide 3 MG/ML / phenylephrine hydrochloride 3.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125104 | Polio virus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125104 | Polio virus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125104 | Polio virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251046 | undecylenic acid 250 MG/ML [Fungoid AF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251047 | undecylenic acid 250 MG/ML Topical Solution [Fungoid AF] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251047 | undecylenic acid 250 MG/ML Topical Solution [Fungoid AF] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251047 | undecylenic acid 250 MG/ML Topical Solution [Fungoid AF] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251048 | glycerin 1610 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251049 | glycerin 80.7 % Adult Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251049 | glycerin 80.7 % Adult Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251049 | glycerin 80.7 % Adult Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251049 | glycerin 80.7 % Adult Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 125105 | Varicella immunoglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125105 | Varicella immunoglobulin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125105 | Varicella immunoglobulin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125105 | Varicella immunoglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251053 | Sani-Supp | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251055 | glycerin Rectal Suppository [Sani-Supp] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251056 | Sani-Supp Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251058 | glycerin 2100 MG [Sani-Supp] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251059 | glycerin 2100 MG Rectal Suppository [Sani-Supp] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251059 | glycerin 2100 MG Rectal Suppository [Sani-Supp] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251059 | glycerin 2100 MG Rectal Suppository [Sani-Supp] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251059 | glycerin 2100 MG Rectal Suppository [Sani-Supp] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125106 | Parasite antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125106 | Parasite antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125106 | Parasite antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251061 | glycerin 1200 MG [Sani-Supp] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251062 | Sani-Supp 1.2 GM Pediatric Rectal Suppository | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251062 | Sani-Supp 1.2 GM Pediatric Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251062 | Sani-Supp 1.2 GM Pediatric Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251062 | Sani-Supp 1.2 GM Pediatric Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251062 | Sani-Supp 1.2 GM Pediatric Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125107 | Naegleria antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125107 | Naegleria antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125108 | Ancylostoma antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125108 | Ancylostoma antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125108 | Ancylostoma antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125109 | Ascaris antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125109 | Ascaris antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125110 | Clonorchis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125110 | Clonorchis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125111 | Cysticercosis antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125111 | Cysticercosis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125111 | Cysticercosis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125112 | Fasciola antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125112 | Fasciola antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125112 | Fasciola antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125113 | Giardia antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125113 | Giardia antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125114 | Malaria antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125114 | Malaria antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125115 | Microfilaria antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125115 | Microfilaria antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125115 | Microfilaria antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125116 | Paragonimus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125116 | Paragonimus antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125116 | Paragonimus antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125117 | Pneumocystis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125117 | Pneumocystis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251174 | glycerin 1200 MG [Colace Glycerin Suppositories] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251175 | Colace Glycerin Suppositories 1.2 GM Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251175 | Colace Glycerin Suppositories 1.2 GM Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251175 | Colace Glycerin Suppositories 1.2 GM Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251175 | Colace Glycerin Suppositories 1.2 GM Rectal Suppository | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125118 | Schistosoma antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125118 | Schistosoma antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125118 | Schistosoma antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251185 | chlorpheniramine maleate 0.8 MG/mL / dextromethorphan hydrobromide 3 MG/mL / phenylephrine hydrochloride 2.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251185 | chlorpheniramine maleate 0.8 MG/mL / dextromethorphan hydrobromide 3 MG/mL / phenylephrine hydrochloride 2.5 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251185 | chlorpheniramine maleate 0.8 MG/mL / dextromethorphan hydrobromide 3 MG/mL / phenylephrine hydrochloride 2.5 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125119 | Strongyloides antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125119 | Strongyloides antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125119 | Strongyloides antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251190 | lactulose 10 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251190 | lactulose 10 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251190 | lactulose 10 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251190 | lactulose 10 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251192 | Kristalose 10 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251192 | Kristalose 10 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251192 | Kristalose 10 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251192 | Kristalose 10 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251192 | Kristalose 10 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251194 | lactulose 20 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251194 | lactulose 20 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251194 | lactulose 20 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251194 | lactulose 20 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251196 | Kristalose 20 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251196 | Kristalose 20 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251196 | Kristalose 20 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251196 | Kristalose 20 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251196 | Kristalose 20 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251199 | chlorhexidine / glycerin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 125120 | Toxocara antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125120 | Toxocara antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251200 | chlorhexidine / glycerin Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251201 | chlorhexidine / glycerin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1251202 | chlorhexidine gluconate 5 MG/ML / glycerin 50 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251203 | Supreme Teat Dip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251204 | chlorhexidine gluconate 5 MG/ML / glycerin 50 MG/ML [Supreme Teat Dip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251205 | chlorhexidine / glycerin Topical Solution [Supreme Teat Dip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251206 | Supreme Teat Dip Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251207 | chlorhexidine gluconate 5 MG/ML / glycerin 50 MG/ML Topical Solution [Supreme Teat Dip] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251207 | chlorhexidine gluconate 5 MG/ML / glycerin 50 MG/ML Topical Solution [Supreme Teat Dip] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251208 | Supreme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251209 | chlorhexidine gluconate 5 MG/ML [Supreme] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 125121 | Trypanosomiasis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125121 | Trypanosomiasis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125121 | Trypanosomiasis antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251210 | chlorhexidine Topical Solution [Supreme] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251211 | Supreme Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251212 | Supreme 0.5 % Chlorhexidene Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251212 | Supreme 0.5 % Chlorhexidene Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251212 | Supreme 0.5 % Chlorhexidene Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251212 | Supreme 0.5 % Chlorhexidene Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125122 | African trypanosomiasis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125122 | African trypanosomiasis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125123 | Chagas' disease antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125123 | Chagas' disease antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125123 | Chagas' disease antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251239 | potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG [K-Phos Neutral] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 125124 | IgA - Salivary immunoglobulin A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125124 | IgA - Salivary immunoglobulin A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125124 | IgA - Salivary immunoglobulin A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251240 | potassium phosphate / sodium phosphate, dibasic / sodium phosphate, monobasic Oral Tablet [K-Phos Neutral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251241 | K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125125 | Specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125125 | Specific immunoglobulin E | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125125 | Specific immunoglobulin E | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125125 | Specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125127 | Delta heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125127 | Delta heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251271 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG [Allerx-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251272 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Allerx-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251273 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Allerx-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251274 | methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251274 | methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251274 | methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251274 | methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251275 | methscopolamine / pseudoephedrine Oral Tablet [Allerx-D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251276 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet [Allerx-D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251276 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet [Allerx-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251277 | clorazepate dipotassium 11.25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251279 | pramoxine HCl 1 % / menthol 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251279 | pramoxine HCl 1 % / menthol 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251279 | pramoxine HCl 1 % / menthol 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 125128 | Epsilon heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125128 | Epsilon heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251280 | PrameGel Reformulated Apr 2012 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1251281 | menthol 0.005 MG/MG / pramoxine hydrochloride 0.01 MG/MG [PrameGel Reformulated Apr 2012] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251282 | menthol / pramoxine Topical Gel [PrameGel Reformulated Apr 2012] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251283 | PrameGel Reformulated Apr 2012 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251284 | PrameGel 0.5 % / 1 % Topical Gel, Reformulated Apr 2012 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251284 | PrameGel 0.5 % / 1 % Topical Gel, Reformulated Apr 2012 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251284 | PrameGel 0.5 % / 1 % Topical Gel, Reformulated Apr 2012 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251285 | Urogesic Blue Reformulated Apr 2012 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1251286 | hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG [Urogesic Blue Reformulated Apr 2012] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251287 | hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet [Urogesic Blue Reformulated Apr 2012] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251288 | Urogesic Blue Reformulated Apr 2012 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251289 | Urogesic Blue Reformulated Apr 2012 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 125129 | Mu heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125129 | Mu heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251290 | UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251290 | UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251290 | UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251292 | testosterone Topical Solution [Axiron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251296 | dextromethorphan HBr 30 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251296 | dextromethorphan HBr 30 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251296 | dextromethorphan HBr 30 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 125130 | Alpha heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125130 | Alpha heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251309 | alginic acid / calcium carbonate / magnesium trisilicate / sodium bicarbonate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 125131 | Gamma heavy chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125131 | Gamma heavy chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251310 | alginic acid / calcium carbonate / magnesium trisilicate / sodium bicarbonate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251311 | alginic acid / calcium carbonate / magnesium trisilicate / sodium bicarbonate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251312 | alginic acid / calcium carbonate / magnesium trisilicate / sodium bicarbonate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1251313 | alginic acid 200 MG / calcium carbonate 80 MG / magnesium trisilicate 20 MG / sodium bicarbonate 70 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251313 | alginic acid 200 MG / calcium carbonate 80 MG / magnesium trisilicate 20 MG / sodium bicarbonate 70 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251313 | alginic acid 200 MG / calcium carbonate 80 MG / magnesium trisilicate 20 MG / sodium bicarbonate 70 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251315 | chlorcyclizine HCl 25 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251315 | chlorcyclizine HCl 25 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251315 | chlorcyclizine HCl 25 MG / pseudoephedrine HCl 60 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251316 | Stahist AD Liquid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251317 | chlorcyclizine hydrochloride 5 MG/ML / pseudoephedrine hydrochloride 12 MG/ML [Stahist AD Liquid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251318 | chlorcyclizine / pseudoephedrine Oral Solution [Stahist AD Liquid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251319 | Stahist AD Liquid Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 125132 | Bence Jones protein - kappa light chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125132 | Bence Jones protein - kappa light chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125132 | Bence Jones protein - kappa light chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251320 | Stahist AD Liquid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251321 | chlorcyclizine hydrochloride 5 MG/ML / pseudoephedrine hydrochloride 12 MG/ML Oral Solution [Stahist AD Liquid] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251321 | chlorcyclizine hydrochloride 5 MG/ML / pseudoephedrine hydrochloride 12 MG/ML Oral Solution [Stahist AD Liquid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251321 | chlorcyclizine hydrochloride 5 MG/ML / pseudoephedrine hydrochloride 12 MG/ML Oral Solution [Stahist AD Liquid] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251322 | norethindrone acetate 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251323 | norethindrone acetate 0.5 MG / ethinyl estradiol 2.5 MCG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251324 | ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG [Femhrt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251325 | femhrt 0.5 MG / 2.5 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251325 | femhrt 0.5 MG / 2.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251325 | femhrt 0.5 MG / 2.5 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251325 | femhrt 0.5 MG / 2.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251325 | femhrt 0.5 MG / 2.5 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251326 | ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG [Femhrt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251327 | ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Femhrt] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251327 | ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Femhrt] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251327 | ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Femhrt] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251329 | cyclizine HCl 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251329 | cyclizine HCl 25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125133 | Bence Jones protein - lambda light chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125133 | Bence Jones protein - lambda light chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125133 | Bence Jones protein - lambda light chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251330 | cyclizine hydrochloride 25 MG [Bonine For Kids] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251331 | Bonine For Kids 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251331 | Bonine For Kids 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251331 | Bonine For Kids 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251334 | Eth estra-Noreth Ac 0.0025-0.5 MG (28) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1251334 | Eth estra-Noreth Ac 0.0025-0.5 MG (28) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251335 | femhrt 0.5/2.5 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1251335 | femhrt 0.5/2.5 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251335 | femhrt 0.5/2.5 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251335 | femhrt 0.5/2.5 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251336 | Eth estra-Noreth Ac 0.005-1 MG (28) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1251336 | Eth estra-Noreth Ac 0.005-1 MG (28) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251337 | femhrt 1/5 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1251337 | femhrt 1/5 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251337 | femhrt 1/5 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251337 | femhrt 1/5 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125134 | LDL - Low density lipoprotein high affinity cell surface receptor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125134 | LDL - Low density lipoprotein high affinity cell surface receptor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125134 | LDL - Low density lipoprotein high affinity cell surface receptor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251346 | activated charcoal 250 MG [Charcoal Plus DS] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251347 | activated charcoal Delayed Release Oral Tablet [Charcoal Plus DS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251348 | Charcoal Plus DS 250 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251348 | Charcoal Plus DS 250 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251348 | Charcoal Plus DS 250 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251349 | activated charcoal 250 MG [Char-Flo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 125135 | PLF - Placental isoferritin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125135 | PLF - Placental isoferritin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125135 | PLF - Placental isoferritin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251350 | activated charcoal Delayed Release Oral Tablet [Char-Flo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251351 | activated charcoal 250 MG Delayed Release Oral Tablet [Char-Flo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251351 | activated charcoal 250 MG Delayed Release Oral Tablet [Char-Flo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251354 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Acid Gone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251355 | Acid Gone 95 MG / 358 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251355 | Acid Gone 95 MG / 358 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251355 | Acid Gone 95 MG / 358 MG in 15 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251355 | Acid Gone 95 MG / 358 MG in 15 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251358 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Alenic Alka] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251359 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Alenic Alka] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251359 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Alenic Alka] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251359 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Alenic Alka] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125136 | Placental protein 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125136 | Placental protein 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251362 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Genaton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251363 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Genaton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251363 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Genaton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251363 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Genaton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251364 | aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251365 | Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251365 | Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251365 | Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251365 | Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 125137 | Placental protein 2 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125137 | Placental protein 2 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251370 | cetylpyridinium chloride 0.7 MG/ML [Crest Mouthwash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251371 | Crest Pro-Health 0.07 % Oral Rinse | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251371 | Crest Pro-Health 0.07 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251371 | Crest Pro-Health 0.07 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251373 | brompheniramine tannate 1.6 MG/ML [Lodrane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251377 | brompheniramine tannate 1.6 MG/ML Extended Release Suspension [Lodrane] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251377 | brompheniramine tannate 1.6 MG/ML Extended Release Suspension [Lodrane] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125138 | Placental protein 3 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125138 | Placental protein 3 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125139 | Placental protein 6 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125139 | Placental protein 6 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251393 | activated charcoal 208 MG/ML [Char-Flo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251394 | activated charcoal Oral Suspension [Char-Flo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251395 | activated charcoal 208 MG/ML Oral Suspension [Char-Flo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251395 | activated charcoal 208 MG/ML Oral Suspension [Char-Flo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251395 | activated charcoal 208 MG/ML Oral Suspension [Char-Flo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251396 | sodium chloride Nasal Spray [Ocean brand of sodium chloride] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251397 | Ocean brand of sodium chloride Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251398 | Ocean Saline 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251398 | Ocean Saline 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251398 | Ocean Saline 0.65 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251398 | Ocean Saline 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251398 | Ocean Saline 0.65 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251399 | dextromethorphan hydrobromide 14 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 125140 | Placental protein 7 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125140 | Placental protein 7 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251400 | phenylephrine hydrochloride 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251401 | dextromethorphan HBr 14 MG / guaiFENesin 288 MG / phenylephrine HCl 7 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251401 | dextromethorphan HBr 14 MG / guaiFENesin 288 MG / phenylephrine HCl 7 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251401 | dextromethorphan HBr 14 MG / guaiFENesin 288 MG / phenylephrine HCl 7 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251406 | Actidose | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1251407 | activated charcoal 208 MG/ML [Actidose] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251408 | activated charcoal Oral Suspension [Actidose] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251409 | Actidose Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 125141 | Procollagen peptide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125141 | Procollagen peptide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251410 | Actidose Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251411 | ACTIDOSE 208 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251415 | ethanol 0.659 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251416 | ethanol 65.9 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251416 | ethanol 65.9 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251416 | ethanol 65.9 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251416 | ethanol 65.9 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 125142 | Hydroxypyridinoline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125142 | Hydroxypyridinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125142 | Hydroxypyridinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251447 | urofollitropin 37.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251448 | urofollitropin 37.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251449 | urofollitropin 37.5 MG/ML [Bravelle] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251450 | urofollitropin 37.5 MG/ML Injectable Solution [Bravelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251450 | urofollitropin 37.5 MG/ML Injectable Solution [Bravelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251450 | urofollitropin 37.5 MG/ML Injectable Solution [Bravelle] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251451 | Ez2go Stimu-Lax Tablet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251452 | bisacodyl 5 MG [Ez2go Stimu-Lax Tablet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251453 | bisacodyl Delayed Release Oral Tablet [Ez2go Stimu-Lax Tablet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251454 | Ez2go Stimu-Lax Tablet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251455 | Ez2go Stimu-Lax Tablet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251456 | Ez2go Stimu-Lax 5 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251456 | Ez2go Stimu-Lax 5 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251456 | Ez2go Stimu-Lax 5 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251458 | camphor 0.005 MG/MG / menthol 0.004 MG/MG / methyl salicylate 0.008 MG/MG [Satohap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251461 | Satohap Pain Relieving Plaster 0.5 % / 0.4 % / 0.8 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251461 | Satohap Pain Relieving Plaster 0.5 % / 0.4 % / 0.8 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251461 | Satohap Pain Relieving Plaster 0.5 % / 0.4 % / 0.8 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251462 | Benzalkonium-containing product in oromucosal dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251462 | Benzalkonium-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251462 | Benzalkonium-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251463 | benzalkonium Mucosal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251464 | benzalkonium chloride 0.13 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251464 | benzalkonium chloride 0.13 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251464 | benzalkonium chloride 0.13 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251465 | Ez2go Stimu-Lax Powder | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251469 | Ez2go Stimu-Lax Powder Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251471 | Ez2go Zero | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251472 | simethicone 80 MG [Ez2go Zero] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251473 | simethicone Chewable Tablet [Ez2go Zero] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251474 | Ez2go Zero Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251475 | Ez2go Zero Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251476 | Ez2go Zero 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251476 | Ez2go Zero 80 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251476 | Ez2go Zero 80 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251482 | Throat-Releev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251483 | benzalkonium chloride 1.3 MG/ML [Throat-Releev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251484 | benzalkonium Mucosal Spray [Throat-Releev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251485 | Throat-Releev Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251486 | Throat-Releev 0.13 % Mucosal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251486 | Throat-Releev 0.13 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251486 | Throat-Releev 0.13 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251486 | Throat-Releev 0.13 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251487 | Shing-Releev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251490 | Shing-Releev Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251492 | norethindrone acetate 0.00583 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251493 | estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251494 | estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR [Combipatch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251495 | Combipatch 50/140 MCG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251495 | Combipatch 50/140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251495 | Combipatch 50/140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251495 | Combipatch 50/140 MCG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251495 | Combipatch 50/140 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251498 | norethindrone acetate 0.0104 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251499 | estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251500 | estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR [Combipatch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251501 | Combipatch 50/250 MCG/Day Twice Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251501 | Combipatch 50/250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251501 | Combipatch 50/250 MCG/Day Twice Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251501 | Combipatch 50/250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251501 | Combipatch 50/250 MCG/Day Twice Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251505 | brompheniramine maleate 4 MG / hydrocodone bitartrate 7.5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251505 | brompheniramine maleate 4 MG / hydrocodone bitartrate 7.5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251505 | brompheniramine maleate 4 MG / hydrocodone bitartrate 7.5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251505 | brompheniramine maleate 4 MG / hydrocodone bitartrate 7.5 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251555 | calcium carbonate 356 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251556 | magnesium oxide 158 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251557 | calcium carbonate 356 MG (Ca 200 MG) / magnesium oxide 158 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251557 | calcium carbonate 356 MG (Ca 200 MG) / magnesium oxide 158 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251558 | clear days ahead | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251559 | salicylic acid 5 MG/ML [clear days ahead] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251560 | salicylic acid Medicated Pad [clear days ahead] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251561 | clear days ahead Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251562 | clear days ahead 0.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251562 | clear days ahead 0.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251562 | clear days ahead 0.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251562 | clear days ahead 0.5 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251563 | salicylic acid 0.02 MG/MG [clear days ahead] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251564 | salicylic acid Topical Gel [clear days ahead] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251565 | clear days ahead Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251566 | philosopy clear days ahead acne spot treatment 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251566 | philosopy clear days ahead acne spot treatment 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251566 | philosopy clear days ahead acne spot treatment 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251566 | philosopy clear days ahead acne spot treatment 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251569 | salicylic acid 10 MG/ML [clear days ahead] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251570 | salicylic acid Topical Cream [clear days ahead] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251571 | clear days ahead 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251571 | clear days ahead 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251571 | clear days ahead 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251571 | clear days ahead 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251572 | salicylic acid Medicated Liquid Soap [clear days ahead] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251574 | clear days ahead 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251574 | clear days ahead 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251574 | clear days ahead 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251574 | clear days ahead 1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251576 | imidacloprid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1251576 | imidacloprid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251576 | imidacloprid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251577 | imidacloprid 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251578 | moxidectin 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251579 | imidacloprid / moxidectin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 125158 | PGK - Phosphoglycerokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125158 | PGK - Phosphoglycerokinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125158 | PGK - Phosphoglycerokinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251580 | imidacloprid / moxidectin Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251581 | imidacloprid / moxidectin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1251582 | imidacloprid 10 % / moxidectin 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251582 | imidacloprid 10 % / moxidectin 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251582 | imidacloprid 10 % / moxidectin 2.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251583 | Advantage Multi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251584 | imidacloprid 100 MG/ML / moxidectin 25 MG/ML [Advantage Multi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251585 | imidacloprid / moxidectin Topical Solution [Advantage Multi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251586 | Advantage Multi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251587 | advantage multi for dogs 10 % / 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251587 | advantage multi for dogs 10 % / 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251587 | advantage multi for dogs 10 % / 2.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251588 | interferon alfa-2b 10000000 UNT/ACTUAT [Intron A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251589 | 6 ACTUAT interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251589 | 6 ACTUAT interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251589 | 6 ACTUAT interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251589 | 6 ACTUAT interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251590 | benzocaine 20 % / cetylpyridinium Cl 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251590 | benzocaine 20 % / cetylpyridinium Cl 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251590 | benzocaine 20 % / cetylpyridinium Cl 0.1 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251596 | Intron A 18,000,000 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251596 | Intron A 18,000,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251596 | Intron A 18,000,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251596 | Intron A 18,000,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251598 | cetylpyridinium chloride 0.07 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251598 | cetylpyridinium chloride 0.07 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251598 | cetylpyridinium chloride 0.07 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251599 | butabarbital sodium 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251600 | butabarbital sodium 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251600 | butabarbital sodium 100 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251600 | butabarbital sodium 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251600 | butabarbital sodium 100 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251600 | butabarbital sodium 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251601 | Butisol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1251602 | butabarbital sodium 100 MG [Butisol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251603 | butabarbital Oral Tablet [Butisol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251604 | Butisol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251605 | Butisol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1251606 | butabarbital sodium 100 MG Oral Tablet [Butisol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251606 | butabarbital sodium 100 MG Oral Tablet [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251606 | butabarbital sodium 100 MG Oral Tablet [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251607 | cetylpyridinium chloride 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251608 | benzocaine 10 MG / cetylpyridinium chloride 2.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251608 | benzocaine 10 MG / cetylpyridinium chloride 2.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251609 | butabarbital sodium 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251610 | butabarbital sodium 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251610 | butabarbital sodium 15 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251610 | butabarbital sodium 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251610 | butabarbital sodium 15 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251610 | butabarbital sodium 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251611 | butabarbital sodium 15 MG [Butisol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251612 | butabarbital sodium 15 MG Oral Tablet [Butisol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251612 | butabarbital sodium 15 MG Oral Tablet [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251612 | butabarbital sodium 15 MG Oral Tablet [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251613 | butabarbital sodium 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251614 | butabarbital sodium 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251614 | butabarbital sodium 30 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251614 | butabarbital sodium 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251614 | butabarbital sodium 30 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251614 | butabarbital sodium 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251615 | butabarbital sodium 30 MG [Butisol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251616 | Butisol Sodium 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251616 | Butisol Sodium 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251616 | Butisol Sodium 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251616 | Butisol Sodium 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251617 | cetylpyridinium chloride 0.05 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251617 | cetylpyridinium chloride 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251617 | cetylpyridinium chloride 0.05 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251618 | cetylpyridinium chloride 0.5 MG/ML [Cepacol Antibacterial Mouthwash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251619 | Cepacol Antibacterial 0.05 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251619 | Cepacol Antibacterial 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251619 | Cepacol Antibacterial 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251619 | Cepacol Antibacterial 0.05 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 125162 | Globin chain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125162 | Globin chain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251620 | butabarbital sodium 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251621 | butabarbital sodium 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251621 | butabarbital sodium 50 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251621 | butabarbital sodium 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251621 | butabarbital sodium 50 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251621 | butabarbital sodium 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251622 | butabarbital sodium 50 MG [Butisol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251623 | Butisol Sodium 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251623 | Butisol Sodium 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251623 | Butisol Sodium 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251623 | Butisol Sodium 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251624 | butabarbital sodium 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251625 | Secbutabarbital sodium 6 mg/mL oral solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251625 | Secbutabarbital sodium 6 mg/mL oral solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251625 | Secbutabarbital sodium 6 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251625 | Secbutabarbital sodium 6 mg/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251626 | butabarbital sodium 6 MG/ML [Butisol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251627 | butabarbital Oral Solution [Butisol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251628 | Butisol Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251629 | butabarbital sodium 6 MG/ML Oral Solution [Butisol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251629 | butabarbital sodium 6 MG/ML Oral Solution [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251629 | butabarbital sodium 6 MG/ML Oral Solution [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251629 | butabarbital sodium 6 MG/ML Oral Solution [Butisol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125164 | Neutrophil myeloperoxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125164 | Neutrophil myeloperoxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125165 | Eosinophil myeloperoxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125165 | Eosinophil myeloperoxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125166 | NAP - Neutrophil alkaline phosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125166 | NAP - Neutrophil alkaline phosphatase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125166 | NAP - Neutrophil alkaline phosphatase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125167 | Chloracetate esterase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125167 | Chloracetate esterase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251673 | Chem-Star IO-Soft 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251674 | iodine 5 MG/ML [Chem-Star IO-Soft 500] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251675 | iodine Topical Solution [Chem-Star IO-Soft 500] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251676 | Chem-Star IO-Soft 500 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251677 | Chem-Star IO-Soft 500 0.5 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251677 | Chem-Star IO-Soft 500 0.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251677 | Chem-Star IO-Soft 500 0.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251677 | Chem-Star IO-Soft 500 0.5 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125168 | Intrinsic pathway clotting factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125168 | Intrinsic pathway clotting factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125168 | Intrinsic pathway clotting factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125168 | Intrinsic pathway clotting factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251680 | Verticalm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251681 | meclizine hydrochloride 25 MG [Verticalm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251682 | meclizine Oral Tablet [Verticalm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251683 | Verticalm Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251684 | Verticalm Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251685 | meclizine hydrochloride 25 MG Oral Tablet [Verticalm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251685 | meclizine hydrochloride 25 MG Oral Tablet [Verticalm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251686 | metroNIDAZOLE 0.0075 MG/MG [Rosadan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251686 | metroNIDAZOLE 0.0075 MG/MG [Rosadan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251687 | metroNIDAZOLE Topical Gel [Rosadan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251687 | metroNIDAZOLE Topical Gel [Rosadan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251688 | Rosadan GEL 0.75 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251688 | Rosadan GEL 0.75 % Topical Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1251688 | Rosadan GEL 0.75 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251688 | Rosadan GEL 0.75 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251688 | Rosadan GEL 0.75 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 125169 | Contact factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125169 | Contact factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251693 | potassium bromide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251694 | potassium bromide Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251696 | KBrovet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251698 | potassium bromide Oral Solution [KBrovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251699 | KBrovet Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 125170 | Extrinsic pathway clotting factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125170 | Extrinsic pathway clotting factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125170 | Extrinsic pathway clotting factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125170 | Extrinsic pathway clotting factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251700 | KBrovet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251702 | potassium bromide 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251703 | potassium bromide 250 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251703 | potassium bromide 250 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251703 | potassium bromide 250 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251703 | potassium bromide 250 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251704 | potassium bromide 250 MG/ML [KBrovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251705 | K+BroVet 250 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251705 | K+BroVet 250 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251705 | K+BroVet 250 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251705 | K+BroVet 250 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251705 | K+BroVet 250 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251706 | potassium bromide 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251707 | potassium bromide Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251708 | potassium bromide 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251708 | potassium bromide 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251708 | potassium bromide 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251708 | potassium bromide 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251709 | potassium bromide 250 MG [KBrovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 125171 | Coagulation system antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125171 | Coagulation system antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125171 | Coagulation system antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251710 | potassium bromide Chewable Tablet [KBrovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251711 | KBrovet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251712 | K+BroVet 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251712 | K+BroVet 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251712 | K+BroVet 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251712 | K+BroVet 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251712 | K+BroVet 250 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251713 | potassium bromide 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251714 | potassium bromide 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251714 | potassium bromide 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251714 | potassium bromide 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251714 | potassium bromide 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251715 | potassium bromide 500 MG [KBrovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251716 | K+BroVet 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251716 | K+BroVet 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251716 | K+BroVet 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251716 | K+BroVet 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251716 | K+BroVet 500 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251719 | progesterone 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 125172 | Factor VIIIc inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125172 | Factor VIIIc inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251720 | progesterone 0.3 GM Vaginal Insert | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251720 | progesterone 0.3 GM Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251720 | progesterone 0.3 GM Vaginal Insert | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251721 | Eazi-Breed CIDR | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251722 | progesterone 300 MG [Eazi-Breed CIDR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251724 | Eazi-Breed CIDR Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251725 | EAZI-BREED CIDR 0.3 GM Vaginal Insert | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251725 | EAZI-BREED CIDR 0.3 GM Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251725 | EAZI-BREED CIDR 0.3 GM Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251725 | EAZI-BREED CIDR 0.3 GM Vaginal Insert | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251726 | linseed oil 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251727 | flaxseed oil 1200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251727 | flaxseed oil 1200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251727 | flaxseed oil 1200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251727 | flaxseed oil 1200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 125173 | Anti factor Xa | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125173 | Anti factor Xa | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251736 | linseed oil 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251737 | linseed oil / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251738 | linseed oil / vitamin E Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251739 | linseed oil / vitamin E Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 125174 | Lupus inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125174 | Lupus inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125174 | Lupus inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251740 | linseed oil / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1251741 | flaxseed oil 500 MG / vitamin E 5 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251741 | flaxseed oil 500 MG / vitamin E 5 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251741 | flaxseed oil 500 MG / vitamin E 5 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251742 | flaxseed oil 1000 MG / vitamin E 1 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251742 | flaxseed oil 1000 MG / vitamin E 1 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251742 | flaxseed oil 1000 MG / vitamin E 1 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251744 | butabarbital sodium 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251745 | belladonna extract, USP 15 MG / butabarbital sodium 15 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251745 | belladonna extract, USP 15 MG / butabarbital sodium 15 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251746 | belladonna extract, USP 3 MG/ML / butabarbital sodium 3 MG/ML [Butibel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251747 | belladonna extract, USP 3 MG/ML / butabarbital sodium 3 MG/ML Oral Solution [Butibel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251747 | belladonna extract, USP 3 MG/ML / butabarbital sodium 3 MG/ML Oral Solution [Butibel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251748 | linseed oil 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251749 | linseed oil / soy protein isolate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251750 | linseed oil / soy protein isolate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1251751 | linseed oil / soy protein isolate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1251752 | linseed oil / soy protein isolate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1251753 | flaxseed extract 250 MG / soy isoflavones 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251753 | flaxseed extract 250 MG / soy isoflavones 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251753 | flaxseed extract 250 MG / soy isoflavones 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251754 | linseed oil 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251755 | flaxseed extract 300 MG / soy isoflavones 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251755 | flaxseed extract 300 MG / soy isoflavones 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251755 | flaxseed extract 300 MG / soy isoflavones 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251756 | diphenhydrAMINE HCl 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251756 | diphenhydrAMINE HCl 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251756 | diphenhydrAMINE HCl 1 % Topical Lotion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251756 | diphenhydrAMINE HCl 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251756 | diphenhydrAMINE HCl 1 % Topical Lotion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251757 | potassium bicarbonate 3 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251758 | potassium citrate 3 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251759 | Pot Acetate 3 MEQ/ML / Pot bicarbonate 3 MEQ/ML / Pot citrate 3 MEQ/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251759 | Pot Acetate 3 MEQ/ML / Pot bicarbonate 3 MEQ/ML / Pot citrate 3 MEQ/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251759 | Pot Acetate 3 MEQ/ML / Pot bicarbonate 3 MEQ/ML / Pot citrate 3 MEQ/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125176 | Fibrinolytic system factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125176 | Fibrinolytic system factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251760 | potassium acetate 3 MEQ/ML / potassium bicarbonate 3 MEQ/ML / potassium citrate 3 MEQ/ML [Tri-K] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251761 | potassium acetate 3 MEQ/ML / potassium bicarbonate 3 MEQ/ML / potassium citrate 3 MEQ/ML Oral Solution [Tri-K] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251761 | potassium acetate 3 MEQ/ML / potassium bicarbonate 3 MEQ/ML / potassium citrate 3 MEQ/ML Oral Solution [Tri-K] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251761 | potassium acetate 3 MEQ/ML / potassium bicarbonate 3 MEQ/ML / potassium citrate 3 MEQ/ML Oral Solution [Tri-K] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251761 | potassium acetate 3 MEQ/ML / potassium bicarbonate 3 MEQ/ML / potassium citrate 3 MEQ/ML Oral Solution [Tri-K] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251763 | Colgate Total Mouthwash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251764 | cetylpyridinium chloride 0.5 MG/ML [Colgate Total Mouthwash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251765 | cetylpyridinium Mouthwash [Colgate Total Mouthwash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251766 | Colgate Total Mouthwash Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251767 | Colgate Total Mouthwash Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251768 | Colgate Total 0.05 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251768 | Colgate Total 0.05 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251768 | Colgate Total 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251768 | Colgate Total 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251769 | diphenhydramine hydrochloride 3.33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251769 | diphenhydramine hydrochloride 3.33 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 125177 | ABO blood group antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125177 | ABO blood group antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125177 | ABO blood group antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125177 | ABO blood group antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251770 | diphenhydramine hydrochloride 50 MG per 15 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251770 | diphenhydramine hydrochloride 50 MG per 15 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251770 | diphenhydramine hydrochloride 50 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251770 | diphenhydramine hydrochloride 50 MG per 15 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251771 | diphenhydramine hydrochloride 25 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251771 | diphenhydramine hydrochloride 25 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251772 | cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251772 | cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251772 | cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251775 | diphenhydramine hydrochloride 50 MG per 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251775 | diphenhydramine hydrochloride 50 MG per 5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251775 | diphenhydramine hydrochloride 50 MG per 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251775 | diphenhydramine hydrochloride 50 MG per 5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251776 | diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251776 | diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251776 | diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 125178 | Ax antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125178 | Ax antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251780 | potassium bicarbonate 7.8 % / sodium bicarbonate 78 % / sodium citrate 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251782 | Pleo Alkala 7.8 % / 78 % / 1.6 % Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251783 | diphenhydramine hydrochloride 10 MG per 5 ML Oral Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251784 | dimethicone 46.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251785 | dimethicone 4.64 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251785 | dimethicone 4.64 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251785 | dimethicone 4.64 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251786 | diphenhydramine tannate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251786 | diphenhydramine tannate 25 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251787 | diphenhydrAMINE tannate 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251787 | diphenhydrAMINE tannate 25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251787 | diphenhydrAMINE tannate 25 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251788 | cetylpyridinium chloride 0.05 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251788 | cetylpyridinium chloride 0.05 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251788 | cetylpyridinium chloride 0.05 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 125179 | I system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125179 | I system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251791 | butabarbital sodium 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251791 | butabarbital sodium 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251792 | butabarbital sodium 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251792 | butabarbital sodium 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251793 | butabarbital sodium 6.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251794 | butabarbital sodium 33.3 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251794 | butabarbital sodium 33.3 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251795 | cetylpyridinium chloride 1.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251796 | benzocaine 10 MG / cetylpyridinium chloride 1.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251797 | cetylpyridinium chloride 1.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251798 | benzocaine 10 MG / cetylpyridinium chloride 1.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251799 | cetylpyridinium chloride 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 125180 | i antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125180 | i antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125180 | i antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125180 | i antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251800 | benzocaine 10 MG / cetylpyridinium chloride 2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251801 | brompheniramine maleate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251802 | brompheniramine maleate 1 MG / phenylephrine HCl 2.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251802 | brompheniramine maleate 1 MG / phenylephrine HCl 2.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251805 | dexbrompheniramine maleate 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251806 | acetaminophen 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251806 | acetaminophen 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251806 | acetaminophen 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251806 | acetaminophen 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251809 | APAP 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251809 | APAP 500 MG / dexbrompheniramine maleate 3 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125181 | e antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125181 | e antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125181 | e antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125181 | e antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125181 | e antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125181 | e antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251811 | chlorpheniramine maleate 1 MG / dextromethorphan HBr 5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251811 | chlorpheniramine maleate 1 MG / dextromethorphan HBr 5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251814 | benzocaine 15 MG / cetylpyridinium chloride 2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251815 | diphenhydramine tannate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251815 | diphenhydramine tannate 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251817 | cetylpyridinium chloride 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251818 | benzocaine 15 MG / cetylpyridinium chloride 5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251818 | benzocaine 15 MG / cetylpyridinium chloride 5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251819 | benzocaine 2 MG / cetylpyridinium chloride 2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125182 | Blood group antigen rh^w1^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251820 | butabarbital sodium 30 MG / methamphetamine HCl 10 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251820 | butabarbital sodium 30 MG / methamphetamine HCl 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251821 | cetylpyridinium chloride 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251822 | benzocaine 2.5 MG / cetylpyridinium chloride 0.2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251823 | benzocaine 2.5 MG / cetylpyridinium chloride 1 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251825 | Q-Sorb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251826 | ubidecarenone 50 MG / vitamin E 5 UNT [Q-Sorb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251827 | ubidecarenone / vitamin E Oral Capsule [Q-Sorb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251828 | Q-Sorb Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251829 | Q-Sorb Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125183 | Blood group antigen rh^x^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251830 | Q-Sorb 50 MG / 5 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251830 | Q-Sorb 50 MG / 5 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251830 | Q-Sorb 50 MG / 5 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251830 | Q-Sorb 50 MG / 5 UNT Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251836 | diphenhydrAMINE HCl 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251836 | diphenhydrAMINE HCl 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251836 | diphenhydrAMINE HCl 2 % Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251836 | diphenhydrAMINE HCl 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251836 | diphenhydrAMINE HCl 2 % Topical Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1251837 | diphenhydramine hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251837 | diphenhydramine hydrochloride 5 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125184 | Blood group antigen rh^w2^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125185 | Rhb antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125185 | Rhb antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125186 | Rhc antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125186 | Rhc antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125187 | Rhd antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125187 | Rhd antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125188 | Rha antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125188 | Rha antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251884 | chlorhexidine gluconate 18.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251885 | chlorhexidine gluconate 1.88 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251885 | chlorhexidine gluconate 1.88 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251885 | chlorhexidine gluconate 1.88 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251889 | Chem-Star Recover | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 125189 | MNS system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125189 | MNS system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125189 | MNS system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251890 | heptanoic acid 15 MG/ML [Chem-Star Recover] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251891 | heptanoic acid Topical Solution [Chem-Star Recover] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251892 | Chem-Star Recover Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251893 | Chem-Star Recover 1.5 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251893 | Chem-Star Recover 1.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251893 | Chem-Star Recover 1.5 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251893 | Chem-Star Recover 1.5 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251894 | Chem-Star Alltra-Dine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1251895 | iodine 2.5 MG/ML [Chem-Star Alltra-Dine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251896 | iodine Topical Solution [Chem-Star Alltra-Dine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251897 | Chem-Star Alltra-Dine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1251898 | CHEM-STAR Alltra-Dine 0.25 % Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251898 | CHEM-STAR Alltra-Dine 0.25 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251898 | CHEM-STAR Alltra-Dine 0.25 % Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251898 | CHEM-STAR Alltra-Dine 0.25 % Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1251899 | iodine 18.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 125190 | Blood group antigen Lu | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125190 | Blood group antigen Lu | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125190 | Blood group antigen Lu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125190 | Blood group antigen Lu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251900 | iodine 1.82 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251900 | iodine 1.82 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251900 | iodine 1.82 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251902 | ethacrynic acid 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251903 | ethacrynic acid 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251903 | ethacrynic acid 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251903 | ethacrynic acid 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1251903 | ethacrynic acid 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251903 | ethacrynic acid 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1251904 | ethacrynic acid 25 MG [Edecrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251905 | Edecrin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251905 | Edecrin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251905 | Edecrin 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251906 | ethacrynic acid 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251907 | ethacrynic acid 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251907 | ethacrynic acid 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251907 | ethacrynic acid 50 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1251907 | ethacrynic acid 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1251907 | ethacrynic acid 50 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1251908 | ethacrynic acid 50 MG [Edecrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1251909 | ethacrynic acid 50 MG Oral Tablet [Edecrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251909 | ethacrynic acid 50 MG Oral Tablet [Edecrin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 125191 | Lub antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125191 | Lub antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125191 | Lub antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125191 | Lub antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125191 | Lub antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251911 | rotigotine 0.0417 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251913 | rotigotine 0.0417 MG/HR [Neupro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251914 | Neupro 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251914 | Neupro 1 MG/Day 24HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251914 | Neupro 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251914 | Neupro 1 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251914 | Neupro 1 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251915 | rotigotine 0.125 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251917 | rotigotine 0.125 MG/HR [Neupro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251918 | Neupro 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251918 | Neupro 3 MG/Day 24HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251918 | Neupro 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251918 | Neupro 3 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251918 | Neupro 3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251919 | rotigotine 0.333 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 125192 | Blood group antigen Lu^ab^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125192 | Blood group antigen Lu^ab^ | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125192 | Blood group antigen Lu^ab^ | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125192 | Blood group antigen Lu^ab^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125192 | Blood group antigen Lu^ab^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251921 | rotigotine 0.333 MG/HR [Neupro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1251922 | Neupro 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251922 | Neupro 8 MG/Day 24HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1251922 | Neupro 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251922 | Neupro 8 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251922 | Neupro 8 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1251928 | acetaminophen 500 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1251928 | acetaminophen 500 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1251928 | acetaminophen 500 MG / chlorpheniramine maleate 2 MG / pseudoephedrine HCl 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 125193 | Blood group antigen Lu1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125193 | Blood group antigen Lu1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125193 | Blood group antigen Lu1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125193 | Blood group antigen Lu1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125193 | Blood group antigen Lu1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1251932 | pangamic acid 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1251933 | pangamic acid 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1251933 | pangamic acid 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125194 | Kpa antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125194 | Kpa antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125194 | Kpa antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125194 | Kpa antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125194 | Kpa antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125195 | Blood group antigen K6 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125195 | Blood group antigen K6 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125195 | Blood group antigen K6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125195 | Blood group antigen K6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125195 | Blood group antigen K6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125196 | Blood group antigen K7 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125196 | Blood group antigen K7 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125196 | Blood group antigen K7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125196 | Blood group antigen K7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125196 | Blood group antigen K7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125197 | Blood group antigen K4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125197 | Blood group antigen K4 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125197 | Blood group antigen K4 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125197 | Blood group antigen K4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125197 | Blood group antigen K4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125198 | Leb antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125198 | Leb antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125198 | Leb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125198 | Leb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125199 | Leab antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125199 | Leab antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125199 | Leab antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125199 | Leab antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125200 | Lea antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125200 | Lea antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125200 | Lea antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125200 | Lea antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252008 | petrolatum 0.996 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1252009 | petrolatum 99.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1252009 | petrolatum 99.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1252009 | petrolatum 99.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125201 | Fyb antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125201 | Fyb antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125201 | Fyb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125201 | Fyb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252015 | {21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Vorele 28 Day] | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1252016 | VIORELE 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1252016 | VIORELE 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1252016 | VIORELE 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1252017 | dodecylbenzenesulfonic acid 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1252018 | dodecylbenzenesulfonic acid / hydrogen peroxide / lactate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1252019 | dodecylbenzenesulfonic acid / hydrogen peroxide / lactate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 125202 | Fy3 antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125202 | Fy3 antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125202 | Fy3 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125202 | Fy3 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252020 | dodecylbenzenesulfonic acid / hydrogen peroxide / lactate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1252021 | hydrogen peroxide 0.5 % / lactic acid 1.7 % / dodecylbenzenesulfonic acid 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252021 | hydrogen peroxide 0.5 % / lactic acid 1.7 % / dodecylbenzenesulfonic acid 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1252021 | hydrogen peroxide 0.5 % / lactic acid 1.7 % / dodecylbenzenesulfonic acid 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1252023 | heptanoic acid 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1252024 | heptanoic acid / iodine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1252025 | heptanoic acid / iodine Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1252026 | heptanoic acid / iodine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1252027 | iodine 1 % / heptanoic acid 0.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252027 | iodine 1 % / heptanoic acid 0.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1252027 | iodine 1 % / heptanoic acid 0.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 125203 | Fy4 antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125203 | Fy4 antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125203 | Fy4 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125203 | Fy4 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125204 | Fy5 antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125204 | Fy5 antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125204 | Fy5 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125204 | Fy5 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125205 | Fy6 antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125205 | Fy6 antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125205 | Fy6 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125205 | Fy6 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125206 | Fya antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125206 | Fya antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125206 | Fya antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125206 | Fya antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125207 | Jka antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125207 | Jka antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125207 | Jka antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125207 | Jka antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125208 | Jkb antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125208 | Jkb antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125208 | Jkb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125208 | Jkb antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125209 | Blood group antigen Rh25 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125209 | Blood group antigen Rh25 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125209 | Blood group antigen Rh25 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125209 | Blood group antigen Rh25 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125209 | Blood group antigen Rh25 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125210 | Blood group antigen Ne^a^ | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125210 | Blood group antigen Ne^a^ | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125210 | Blood group antigen Ne^a^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125210 | Blood group antigen Ne^a^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125210 | Blood group antigen Ne^a^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125211 | Dombrock system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125211 | Dombrock system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125211 | Dombrock system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125212 | Colton system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125212 | Colton system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125212 | Colton system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125213 | Scianna system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125213 | Scianna system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125213 | Scianna system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125214 | Xg system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125214 | Xg system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125214 | Xg system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125215 | Cartwright system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125215 | Cartwright system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125215 | Cartwright system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125215 | Cartwright system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125216 | Diego system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125216 | Diego system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125216 | Diego system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125217 | Chido-Rogers system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125217 | Chido-Rogers system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125217 | Chido-Rogers system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125218 | Kx system antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125218 | Kx system antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125218 | Kx system antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125219 | Low incidence blood group antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125219 | Low incidence blood group antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125220 | Wright antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125220 | Wright antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125223 | SAP - Serum amyloid P | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125223 | SAP - Serum amyloid P | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125223 | SAP - Serum amyloid P | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1252230 | calamine 2 % / zinc oxide 12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1252230 | calamine 2 % / zinc oxide 12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1252230 | calamine 2 % / zinc oxide 12 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1252230 | calamine 2 % / zinc oxide 12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1252239 | witch hazel 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 125224 | Classical complement pathway factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125224 | Classical complement pathway factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125224 | Classical complement pathway factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1252240 | witch hazel Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1252241 | witch hazel 0.15 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1252241 | witch hazel 0.15 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1252241 | witch hazel 0.15 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 125226 | Terminal complement pathway factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125226 | Terminal complement pathway factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125227 | C5a - inactivated complement component 5a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125227 | C5a - inactivated complement component 5a | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125227 | C5a - inactivated complement component 5a | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125228 | C5a des-Arg - Inactivated complement component 5a | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125228 | C5a des-Arg - Inactivated complement component 5a | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125229 | Alternative complement pathway factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125229 | Alternative complement pathway factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125229 | Alternative complement pathway factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125230 | Complement regulatory factor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125230 | Complement regulatory factor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125231 | Complement component 1q antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125231 | Complement component 1q antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125232 | Complement allotype | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125232 | Complement allotype | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125233 | Complement 4 allotype | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125233 | Complement 4 allotype | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125234 | Factor B allotype | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125234 | Factor B allotype | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125235 | Complement 2 allotype | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125235 | Complement 2 allotype | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125236 | C1r: C1s: C1 - Complement component 1r: Complement component 1s: Complement component 1 inhibitor activation complex | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125236 | C1r: C1s: C1 - Complement component 1r: Complement component 1s: Complement component 1 inhibitor activation complex | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125237 | Complement component 3bBbP activation complex | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125237 | Complement component 3bBbP activation complex | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125239 | Organ-specific antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125239 | Organ-specific antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125240 | Endocrine antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125240 | Endocrine antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125241 | Insulin-like growth factor 1 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125241 | Insulin-like growth factor 1 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125242 | Anti-insulin receptor antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125242 | Anti-insulin receptor antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125242 | Anti-insulin receptor antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125243 | Anti-ovary antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125243 | Anti-ovary antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125243 | Anti-ovary antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125243 | Anti-ovary antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125243 | Anti-ovary antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125244 | Anti-parathyroid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125244 | Anti-parathyroid antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125244 | Anti-parathyroid antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125245 | Anti-pituitary antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125245 | Anti-pituitary antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125245 | Anti-pituitary antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125246 | Anti-steroid cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125246 | Anti-steroid cell antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125246 | Anti-steroid cell antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125247 | Anti-testis antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125247 | Anti-testis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125247 | Anti-testis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125247 | Anti-testis antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125249 | Thyroglobulin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125249 | Thyroglobulin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125249 | Thyroglobulin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125250 | Thyroid growth-promoting immunoglobulin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125250 | Thyroid growth-promoting immunoglobulin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125251 | Exophthalmos-producing antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125251 | Exophthalmos-producing antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125251 | Exophthalmos-producing antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125252 | T4ab - thyroxine antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125252 | T4ab - thyroxine antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125252 | T4ab - thyroxine antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125252 | T4ab - thyroxine antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125252 | T4ab - thyroxine antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125253 | Muscle antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125253 | Muscle antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125253 | Muscle antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125253 | Muscle antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125254 | Anti-ganglioside monosialic acid antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125255 | GAD - Glutamic acid decarboxylase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125255 | GAD - Glutamic acid decarboxylase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125255 | GAD - Glutamic acid decarboxylase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125255 | GAD - Glutamic acid decarboxylase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125256 | Myelin-associated glycoprotein antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125256 | Myelin-associated glycoprotein antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125256 | Myelin-associated glycoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125256 | Myelin-associated glycoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125257 | Anti-Purkinje cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125257 | Anti-Purkinje cell antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125257 | Anti-Purkinje cell antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125257 | Anti-Purkinje cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125257 | Anti-Purkinje cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125258 | Anti-retina antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125258 | Anti-retina antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125258 | Anti-retina antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125258 | Anti-retina antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125259 | Voltage-gated calcium-channel antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125259 | Voltage-gated calcium-channel antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125260 | Basal membrane antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125260 | Basal membrane antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125261 | ABM - Alveolar basement membrane antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125261 | ABM - Alveolar basement membrane antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125261 | ABM - Alveolar basement membrane antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125261 | ABM - Alveolar basement membrane antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125261 | ABM - Alveolar basement membrane antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125262 | TBM - Tubular basement membrane antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125262 | TBM - Tubular basement membrane antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125262 | TBM - Tubular basement membrane antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125262 | TBM - Tubular basement membrane antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125264 | Herpes gestationis antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125264 | Herpes gestationis antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125265 | Basal membrane zone antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125265 | Basal membrane zone antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125265 | Basal membrane zone antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125265 | Basal membrane zone antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125266 | Intercellular substance antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125266 | Intercellular substance antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125266 | Intercellular substance antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125267 | Salivary gland duct antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125267 | Salivary gland duct antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125267 | Salivary gland duct antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125268 | Non-organ specific antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125268 | Non-organ specific antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125269 | Anti endomysial antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125269 | Anti endomysial antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125269 | Anti endomysial antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125269 | Anti endomysial antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125269 | Anti endomysial antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125270 | AECA - Anti-endothelial cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125270 | AECA - Anti-endothelial cell antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125270 | AECA - Anti-endothelial cell antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125270 | AECA - Anti-endothelial cell antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125271 | Paraneoplastic antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125271 | Paraneoplastic antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125272 | p-29 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125272 | p-29 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125272 | p-29 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125272 | p-29 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125272 | p-29 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125272 | p-29 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125272 | p-29 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125273 | CAP-57 antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125273 | CAP-57 antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125274 | Eosinophil peroxidase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125274 | Eosinophil peroxidase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125275 | Elastase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125275 | Elastase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125276 | Lactoferrin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125276 | Lactoferrin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125277 | Lysozyme antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125277 | Lysozyme antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125278 | Beta-glucuronidase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125278 | Beta-glucuronidase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125279 | MPO - Myeloperoxidase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125279 | MPO - Myeloperoxidase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125279 | MPO - Myeloperoxidase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125279 | MPO - Myeloperoxidase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125279 | MPO - Myeloperoxidase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125280 | Cathepsin G antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125280 | Cathepsin G antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125281 | APSA - Phosphatidylserine antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125281 | APSA - Phosphatidylserine antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125281 | APSA - Phosphatidylserine antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125281 | APSA - Phosphatidylserine antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125282 | Anti-collagen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125282 | Anti-collagen antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125282 | Anti-collagen antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125282 | Anti-collagen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125283 | Anti-68kDn (hsp-70) inner ear antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125283 | Anti-68kDn (hsp-70) inner ear antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125283 | Anti-68kDn (hsp-70) inner ear antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125283 | Anti-68kDn (hsp-70) inner ear antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125284 | Collagen antibody - type II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125284 | Collagen antibody - type II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125284 | Collagen antibody - type II | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125284 | Collagen antibody - type II | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125284 | Collagen antibody - type II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125285 | Alanyl t-RNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125285 | Alanyl t-RNA synthetase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125285 | Alanyl t-RNA synthetase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125286 | snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125286 | snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125286 | snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125287 | Ki antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125287 | Ki antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125288 | Pm-1 - Polymyositis-scleroderma antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125288 | Pm-1 - Polymyositis-scleroderma antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125288 | Pm-1 - Polymyositis-scleroderma antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125288 | Pm-1 - Polymyositis-scleroderma antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125289 | Sjögren's syndrome - B antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125289 | Sjögren's syndrome - B antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125289 | Sjögren's syndrome - B antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125289 | Sjögren's syndrome - B antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125289 | Sjögren's syndrome - B antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125290 | Ribosomal antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125290 | Ribosomal antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125290 | Ribosomal antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125291 | Ribonucleoprotein antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125292 | Rp - ribosomal peptide antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125292 | Rp - ribosomal peptide antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125292 | Rp - ribosomal peptide antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125292 | Rp - ribosomal peptide antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125292 | Rp - ribosomal peptide antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125293 | Threonyl t-RNA synthetase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125293 | Threonyl t-RNA synthetase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125293 | Threonyl t-RNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125294 | Ku antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125294 | Ku antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125295 | Pyruvate dehydrogenase complex antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125295 | Pyruvate dehydrogenase complex antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125295 | Pyruvate dehydrogenase complex antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125296 | Mitochondrial antibody - type 8 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125296 | Mitochondrial antibody - type 8 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125297 | Mitochondrial antibody - type 9 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125297 | Mitochondrial antibody - type 9 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125298 | Mitochondrial antibody - type 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125298 | Mitochondrial antibody - type 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125299 | Sulfite oxidase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125299 | Sulfite oxidase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125299 | Sulfite oxidase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125300 | Mitochondrial antibody - type 5 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125300 | Mitochondrial antibody - type 5 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125301 | Anti-reticulin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125301 | Anti-reticulin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125301 | Anti-reticulin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125301 | Anti-reticulin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125302 | Reticulin antibody - type 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125302 | Reticulin antibody - type 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125303 | Reticulin antibody - type 2 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125303 | Reticulin antibody - type 2 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125304 | Cytoskeletal antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125304 | Cytoskeletal antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125305 | Anti-vimentin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125305 | Anti-vimentin antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125305 | Anti-vimentin antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125308 | Soluble cluster of differentiation antigen 23 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125308 | Soluble cluster of differentiation antigen 23 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125309 | CDw32 - Cluster of differentiation antigen (workshop) 32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125310 | CD45RC - Cluster of differentiation antigen 45RC | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125310 | CD45RC - Cluster of differentiation antigen 45RC | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125310 | CD45RC - Cluster of differentiation antigen 45RC | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125312 | CDw70 - Cluster of differentiation antigen (workshop) 70 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125312 | CDw70 - Cluster of differentiation antigen (workshop) 70 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125312 | CDw70 - Cluster of differentiation antigen (workshop) 70 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125313 | CD78 - Cluster of differentiation antigen 78 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125313 | CD78 - Cluster of differentiation antigen 78 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125313 | CD78 - Cluster of differentiation antigen 78 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125328 | Human leukocyte antigen class I type antigen A1 - B57 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125328 | Human leukocyte antigen class I type antigen A1 - B57 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125328 | Human leukocyte antigen class I type antigen A1 - B57 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125329 | HLA - Human leukocyte antigen A203 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125329 | HLA - Human leukocyte antigen A203 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125329 | HLA - Human leukocyte antigen A203 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125329 | HLA - Human leukocyte antigen A203 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125329 | HLA - Human leukocyte antigen A203 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125330 | HLA - Human leukocyte antigen A210 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125330 | HLA - Human leukocyte antigen A210 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125330 | HLA - Human leukocyte antigen A210 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125330 | HLA - Human leukocyte antigen A210 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125330 | HLA - Human leukocyte antigen A210 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125331 | HLA - Human leukocyte antigen A2403 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125331 | HLA - Human leukocyte antigen A2403 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125331 | HLA - Human leukocyte antigen A2403 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125331 | HLA - Human leukocyte antigen A2403 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125331 | HLA - Human leukocyte antigen A2403 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125332 | Human leukocyte antigen A32 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125333 | Human leukocyte antigen Aw34 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125334 | Human leukocyte antigen Aw36 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125335 | Human leukocyte antigen Aw66 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125336 | Human leukocyte antigen Aw69 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125337 | Human leukocyte antigen Aw74 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125338 | HLA - Human leukocyte antigen B703 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125338 | HLA - Human leukocyte antigen B703 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125338 | HLA - Human leukocyte antigen B703 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125338 | HLA - Human leukocyte antigen B703 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125338 | HLA - Human leukocyte antigen B703 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125339 | HLA - Human leukocyte antigen B3901 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125339 | HLA - Human leukocyte antigen B3901 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125339 | HLA - Human leukocyte antigen B3901 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125339 | HLA - Human leukocyte antigen B3901 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125339 | HLA - Human leukocyte antigen B3901 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125340 | HLA - Human leukocyte antigen B4005 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125340 | HLA - Human leukocyte antigen B4005 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125340 | HLA - Human leukocyte antigen B4005 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125340 | HLA - Human leukocyte antigen B4005 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125340 | HLA - Human leukocyte antigen B4005 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125341 | HLA - Human leukocyte antigen B42 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125341 | HLA - Human leukocyte antigen B42 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125341 | HLA - Human leukocyte antigen B42 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125341 | HLA - Human leukocyte antigen B42 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125341 | HLA - Human leukocyte antigen B42 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125342 | Human leucocyte antigen B50(21) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125342 | Human leucocyte antigen B50(21) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125342 | Human leucocyte antigen B50(21) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125342 | Human leucocyte antigen B50(21) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125342 | Human leucocyte antigen B50(21) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125343 | HLA - Human leukocyte antigen B5103 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125343 | HLA - Human leukocyte antigen B5103 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125343 | HLA - Human leukocyte antigen B5103 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125343 | HLA - Human leukocyte antigen B5103 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125343 | HLA - Human leukocyte antigen B5103 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125344 | HLA - Human leukocyte antigen B54(22) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125344 | HLA - Human leukocyte antigen B54(22) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125344 | HLA - Human leukocyte antigen B54(22) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125344 | HLA - Human leukocyte antigen B54(22) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125344 | HLA - Human leukocyte antigen B54(22) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125345 | HLA - Human leukocyte antigen B55(22) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125345 | HLA - Human leukocyte antigen B55(22) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125345 | HLA - Human leukocyte antigen B55(22) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125345 | HLA - Human leukocyte antigen B55(22) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125345 | HLA - Human leukocyte antigen B55(22) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125346 | HLA - Human leukocyte antigen B57(17) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125346 | HLA - Human leukocyte antigen B57(17) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125346 | HLA - Human leukocyte antigen B57(17) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125346 | HLA - Human leukocyte antigen B57(17) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125346 | HLA - Human leukocyte antigen B57(17) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125347 | HLA - Human leukocyte antigen B58(17) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125347 | HLA - Human leukocyte antigen B58(17) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125347 | HLA - Human leukocyte antigen B58(17) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125347 | HLA - Human leukocyte antigen B58(17) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125347 | HLA - Human leukocyte antigen B58(17) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125348 | Human leucocyte antigen B3902 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125348 | Human leucocyte antigen B3902 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125348 | Human leucocyte antigen B3902 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125348 | Human leucocyte antigen B3902 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125348 | Human leucocyte antigen B3902 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125349 | HLA - Human leukocyte antigen B48 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125349 | HLA - Human leukocyte antigen B48 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125349 | HLA - Human leukocyte antigen B48 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125349 | HLA - Human leukocyte antigen B48 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125349 | HLA - Human leukocyte antigen B48 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125350 | HLA - Human leukocyte antigen B5102 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125350 | HLA - Human leukocyte antigen B5102 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125350 | HLA - Human leukocyte antigen B5102 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125350 | HLA - Human leukocyte antigen B5102 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125350 | HLA - Human leukocyte antigen B5102 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125351 | HLA - Human leukocyte antigen B56(22) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125351 | HLA - Human leukocyte antigen B56(22) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125351 | HLA - Human leukocyte antigen B56(22) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125351 | HLA - Human leukocyte antigen B56(22) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125351 | HLA - Human leukocyte antigen B56(22) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125352 | Human leukocyte antigen class I type antigen B59 - Cw10 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125352 | Human leukocyte antigen class I type antigen B59 - Cw10 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125352 | Human leukocyte antigen class I type antigen B59 - Cw10 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125353 | Human leucocyte antigen B60(40) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125353 | Human leucocyte antigen B60(40) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125353 | Human leucocyte antigen B60(40) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125353 | Human leucocyte antigen B60(40) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125353 | Human leucocyte antigen B60(40) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125354 | HLA - Human leukocyte antigen B61(40) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125354 | HLA - Human leukocyte antigen B61(40) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125354 | HLA - Human leukocyte antigen B61(40) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125354 | HLA - Human leukocyte antigen B61(40) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125354 | HLA - Human leukocyte antigen B61(40) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125355 | HLA - Human leukocyte antigen B63(15) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125355 | HLA - Human leukocyte antigen B63(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125355 | HLA - Human leukocyte antigen B63(15) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125355 | HLA - Human leukocyte antigen B63(15) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125355 | HLA - Human leukocyte antigen B63(15) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125356 | HLA - Human leukocyte antigen B64(14) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125356 | HLA - Human leukocyte antigen B64(14) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125356 | HLA - Human leukocyte antigen B64(14) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125356 | HLA - Human leukocyte antigen B64(14) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125356 | HLA - Human leukocyte antigen B64(14) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125357 | HLA - Human leukocyte antigen B71(70) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125357 | HLA - Human leukocyte antigen B71(70) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125357 | HLA - Human leukocyte antigen B71(70) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125357 | HLA - Human leukocyte antigen B71(70) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125357 | HLA - Human leukocyte antigen B71(70) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125358 | HLA - Human leukocyte antigen B72(70) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125358 | HLA - Human leukocyte antigen B72(70) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125358 | HLA - Human leukocyte antigen B72(70) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125358 | HLA - Human leukocyte antigen B72(70) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125358 | HLA - Human leukocyte antigen B72(70) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125359 | Human leucocyte antigen B75(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125359 | Human leucocyte antigen B75(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125359 | Human leucocyte antigen B75(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125359 | Human leucocyte antigen B75(15) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125359 | Human leucocyte antigen B75(15) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125360 | HLA - Human leukocyte antigen B76(15) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125360 | HLA - Human leukocyte antigen B76(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125360 | HLA - Human leukocyte antigen B76(15) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125360 | HLA - Human leukocyte antigen B76(15) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125360 | HLA - Human leukocyte antigen B76(15) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125361 | HLA - Human leukocyte antigen B77(15) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125361 | HLA - Human leukocyte antigen B77(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125361 | HLA - Human leukocyte antigen B77(15) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125361 | HLA - Human leukocyte antigen B77(15) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125361 | HLA - Human leukocyte antigen B77(15) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125362 | HLA - Human leukocyte antigen B7801 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125362 | HLA - Human leukocyte antigen B7801 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125362 | HLA - Human leukocyte antigen B7801 | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125362 | HLA - Human leukocyte antigen B7801 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125362 | HLA - Human leukocyte antigen B7801 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125363 | HLA - Human leukocyte antigen B62(15) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125363 | HLA - Human leukocyte antigen B62(15) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125363 | HLA - Human leukocyte antigen B62(15) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125363 | HLA - Human leukocyte antigen B62(15) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125363 | HLA - Human leukocyte antigen B62(15) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125364 | HLA - Human leukocyte antigen Dw13 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125365 | HLA - Human leukocyte antigen DR11(5) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125365 | HLA - Human leukocyte antigen DR11(5) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125365 | HLA - Human leukocyte antigen DR11(5) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125365 | HLA - Human leukocyte antigen DR11(5) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125365 | HLA - Human leukocyte antigen DR11(5) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125366 | HLA - Human leukocyte antigen DR12(5) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125366 | HLA - Human leukocyte antigen DR12(5) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125366 | HLA - Human leukocyte antigen DR12(5) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125366 | HLA - Human leukocyte antigen DR12(5) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125366 | HLA - Human leukocyte antigen DR12(5) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125367 | HLA - Human leukocyte antigen DR13(6) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125367 | HLA - Human leukocyte antigen DR13(6) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125367 | HLA - Human leukocyte antigen DR13(6) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125367 | HLA - Human leukocyte antigen DR13(6) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125367 | HLA - Human leukocyte antigen DR13(6) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125368 | HLA - Human leukocyte antigen DR15(2) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125368 | HLA - Human leukocyte antigen DR15(2) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125368 | HLA - Human leukocyte antigen DR15(2) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125368 | HLA - Human leukocyte antigen DR15(2) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125368 | HLA - Human leukocyte antigen DR15(2) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125369 | HLA - Human leukocyte antigen DR16(2) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125369 | HLA - Human leukocyte antigen DR16(2) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125369 | HLA - Human leukocyte antigen DR16(2) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125369 | HLA - Human leukocyte antigen DR16(2) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125369 | HLA - Human leukocyte antigen DR16(2) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 12537 | 11,17,18,21-tetrahydroxypregn-4-ene-3,20-dione | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 12537 | 11,17,18,21-tetrahydroxypregn-4-ene-3,20-dione | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 12537 | 11,17,18,21-tetrahydroxypregn-4-ene-3,20-dione | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125370 | HLA - Human leukocyte antigen DR18(3) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125370 | HLA - Human leukocyte antigen DR18(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125370 | HLA - Human leukocyte antigen DR18(3) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125370 | HLA - Human leukocyte antigen DR18(3) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125370 | HLA - Human leukocyte antigen DR18(3) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125371 | HLA - Human leukocyte antigen DQ6(1) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125371 | HLA - Human leukocyte antigen DQ6(1) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125371 | HLA - Human leukocyte antigen DQ6(1) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125371 | HLA - Human leukocyte antigen DQ6(1) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125371 | HLA - Human leukocyte antigen DQ6(1) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125372 | HLA - Human leukocyte antigen DQ7(3) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125372 | HLA - Human leukocyte antigen DQ7(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125372 | HLA - Human leukocyte antigen DQ7(3) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125372 | HLA - Human leukocyte antigen DQ7(3) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125372 | HLA - Human leukocyte antigen DQ7(3) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125373 | HLA - Human leukocyte antigen DQ8(3) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125373 | HLA - Human leukocyte antigen DQ8(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125373 | HLA - Human leukocyte antigen DQ8(3) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125373 | HLA - Human leukocyte antigen DQ8(3) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125373 | HLA - Human leukocyte antigen DQ8(3) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125374 | HLA - Human leukocyte antigen DR14(6) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125374 | HLA - Human leukocyte antigen DR14(6) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125374 | HLA - Human leukocyte antigen DR14(6) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125374 | HLA - Human leukocyte antigen DR14(6) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125374 | HLA - Human leukocyte antigen DR14(6) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125375 | Human leucocyte antigen DR17(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125375 | Human leucocyte antigen DR17(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125375 | Human leucocyte antigen DR17(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125375 | Human leucocyte antigen DR17(3) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125375 | Human leucocyte antigen DR17(3) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125376 | HLA - Human leukocyte antigen DQ5(1) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125376 | HLA - Human leukocyte antigen DQ5(1) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125376 | HLA - Human leukocyte antigen DQ5(1) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125376 | HLA - Human leukocyte antigen DQ5(1) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125376 | HLA - Human leukocyte antigen DQ5(1) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 125377 | HLA - Human leukocyte antigen DQ9(3) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125377 | HLA - Human leukocyte antigen DQ9(3) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 125377 | HLA - Human leukocyte antigen DQ9(3) | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 125377 | HLA - Human leukocyte antigen DQ9(3) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 125377 | HLA - Human leukocyte antigen DQ9(3) | Full form of descriptor (FN) | NO | |